Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Lyke, KE; Atmar, RL; Islas, CD; Posavad, CM; Szydlo, D; Paul Chourdhury, R; Deming, ME; Eaton, A; Jackson, LA; Branche, AR; et al.
2022;
3.
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004).
Munoz, FM; Posavad, CM; Richardson, BA; Badell, ML; Bunge, K; Mulligan, MJ; Parameswaran, L; Kelly, C; Olsen-Chen, C; Novak, RM; et al.
2022.
Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al.
New England Journal of Medicine.
2022;
386:1046-1057.
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report.
Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al.
2021.
Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients.
Aljaberi, N; Ghulam, E; Smitherman, EA; Favier, L; Dykes, DM H; Danziger-Isakov, LA; Brady, RC; Huggins, J.
Journal of Rheumatology.
2021;
48:1314-1321.
Meningococcal Infections in Children and Adolescents: Update and Prevention.
Brady, RC.
Bacterial Meningitis.
Huang, FS; Brady, RC; Mortensen, J.
Introduction to Clinical Infectious Diseases.
2019.
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein, DI; Pasetti, MF; Brady, R; Buskirk, AD; Wahid, R; Dickey, M; Cohen, M; Baughman, H; El-Khorazaty, J; Maier, N; et al.
Vaccine.
2019;
37:602-611.
Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
Brady, RC; Jackson, LA; Frey, SE; Shane, AL; Walter, EB; Swamy, GK; Schlaudecker, EP; Szefer, E; Wolff, M; McNeal, MM; et al.
Vaccine.
2018;
36:4663-4671.
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson, LA; El Sahly, HM; George, S; Winokur, P; Edwards, K; Brady, RC; Rouphael, N; Keitel, WA; Mulligan, MJ; Burton, RL; et al.
Vaccine.
2018;
36:606-614.